Measured Wealth Private Client Group LLC Trims Stock Position in The Cigna Group (NYSE:CI)

Measured Wealth Private Client Group LLC reduced its position in The Cigna Group (NYSE:CI) by 24.7% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,291 shares of the health services provider’s stock after selling 423 shares during the quarter. Measured Wealth Private Client Group LLC’s holdings in The Cigna Group were worth $469,000 as of its most recent SEC filing.

Other large investors also recently bought and sold shares of the company. Verum Partners LLC boosted its position in The Cigna Group by 8.8% in the first quarter. Verum Partners LLC now owns 806 shares of the health services provider’s stock valued at $293,000 after buying an additional 65 shares during the last quarter. Capital Advisors Ltd. LLC boosted its holdings in shares of The Cigna Group by 10.6% in the 1st quarter. Capital Advisors Ltd. LLC now owns 335 shares of the health services provider’s stock valued at $122,000 after acquiring an additional 32 shares during the last quarter. Woodmont Investment Counsel LLC acquired a new stake in shares of The Cigna Group in the first quarter worth $397,000. Allspring Global Investments Holdings LLC raised its holdings in shares of The Cigna Group by 7.4% during the first quarter. Allspring Global Investments Holdings LLC now owns 315,083 shares of the health services provider’s stock worth $114,435,000 after purchasing an additional 21,645 shares during the last quarter. Finally, Claro Advisors LLC lifted its position in The Cigna Group by 9.3% during the first quarter. Claro Advisors LLC now owns 1,395 shares of the health services provider’s stock valued at $507,000 after purchasing an additional 119 shares during the period. Institutional investors own 86.99% of the company’s stock.

The Cigna Group Price Performance

Shares of The Cigna Group stock traded down $0.36 during mid-day trading on Tuesday, reaching $325.91. 1,055,980 shares of the stock traded hands, compared to its average volume of 1,616,527. The company has a quick ratio of 0.71, a current ratio of 0.71 and a debt-to-equity ratio of 0.75. The business has a 50-day moving average of $340.69 and a 200 day moving average of $333.60. The stock has a market capitalization of $92.58 billion, a PE ratio of 26.76, a PEG ratio of 1.01 and a beta of 0.52. The Cigna Group has a fifty-two week low of $253.95 and a fifty-two week high of $365.71.

The Cigna Group (NYSE:CI) last posted its quarterly earnings data on Thursday, May 2nd. The health services provider reported $6.47 EPS for the quarter, beating the consensus estimate of $6.17 by $0.30. The Cigna Group had a return on equity of 17.24% and a net margin of 1.76%. The firm had revenue of $57.25 billion during the quarter, compared to the consensus estimate of $56.59 billion. During the same period in the prior year, the company earned $5.41 EPS. The firm’s revenue was up 23.2% compared to the same quarter last year. On average, analysts predict that The Cigna Group will post 28.48 EPS for the current year.

The Cigna Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Thursday, June 20th. Investors of record on Tuesday, June 4th were given a dividend of $1.40 per share. The ex-dividend date of this dividend was Tuesday, June 4th. This represents a $5.60 dividend on an annualized basis and a yield of 1.72%. The Cigna Group’s payout ratio is presently 45.98%.

Analyst Upgrades and Downgrades

A number of analysts have recently commented on the company. Morgan Stanley restated an “overweight” rating and issued a $392.00 target price (up previously from $382.00) on shares of The Cigna Group in a research note on Monday, March 4th. Barclays assumed coverage on The Cigna Group in a research report on Wednesday, March 6th. They issued an “overweight” rating and a $393.00 price objective on the stock. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $400.00 target price on shares of The Cigna Group in a report on Wednesday, June 12th. Baird R W raised shares of The Cigna Group to a “strong-buy” rating in a report on Thursday, May 30th. Finally, JPMorgan Chase & Co. raised their price target on shares of The Cigna Group from $432.00 to $435.00 and gave the company an “overweight” rating in a research report on Thursday, May 30th. Two analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Buy” and an average price target of $376.20.

Insider Activity at The Cigna Group

In related news, Director Elder Granger sold 547 shares of the stock in a transaction that occurred on Monday, June 17th. The stock was sold at an average price of $331.38, for a total value of $181,264.86. Following the completion of the sale, the director now owns 5,471 shares of the company’s stock, valued at $1,812,979.98. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. In other news, SVP Hoeltzel Mary T. Agoglia sold 5,946 shares of the stock in a transaction that occurred on Tuesday, May 14th. The shares were sold at an average price of $348.71, for a total value of $2,073,429.66. Following the completion of the sale, the senior vice president now owns 2,595 shares of the company’s stock, valued at approximately $904,902.45. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Elder Granger sold 547 shares of The Cigna Group stock in a transaction that occurred on Monday, June 17th. The shares were sold at an average price of $331.38, for a total transaction of $181,264.86. Following the sale, the director now directly owns 5,471 shares in the company, valued at approximately $1,812,979.98. The disclosure for this sale can be found here. In the last quarter, insiders sold 22,988 shares of company stock valued at $7,975,726. Corporate insiders own 0.70% of the company’s stock.

The Cigna Group Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.